Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Other agents in development include mazdutide , cagrilintide , survodutide, and orforglipron (an oral small-molecule GLP-1 agonist)
Start your intake Understanding GLP-1 Medications and Multiple Sclerosis GLP-1 receptor agonists work by signaling fullness to the brain, slowing stomach emptying, and improving blood sugar controlmechanisms that do not directly interact with the immune system abnormalities seen in MS
Biochem Biophys Res Commun, 1995
Serious but Rare Risks GLP-1 medications can aggravate or trigger severe pancreatic inflammation in some patients. Both oral and injectable GLP-1 medications may cause gallbladder disease, and in rare cases involving patients with relevant risk factors, there have been associations with thyroid changes observed in animal studies. A serious allergic reaction is possible but uncommon
